FUNDING
Key Metrics
Valuation
$10.3B
As of Jul 31, 2026Value Add Pulse research
Rumoredup to $30B (in talks) · Aug 2026 · Wikipedia
Total funding
$850M
As of Jul 31, 2026Value Add Pulse research
Company Snapshot
Colossal Biosciences is a Biotech company, based in Dallas, Texas, USA, founded 2021 by George Church, Ben Lamm. Latest valuation $10.3B (As of Jul 31, 2026, Value Add Pulse research). Total funding $850M (As of Jul 31, 2026).
Recent changes
- Jul 31, 2026Jul 31, 2026First reported valuation: $10.3B Value Add Pulse enrichment
- Jul 20, 2026Jul 20, 2026Raised $20B at a $30B valuation TechCrunch
- Jul 20, 2026Jul 20, 2026Colossal Biosciences in Talks to Raise at $20B-$30B Valuation Pulse story
- Jul 20, 2026Jul 20, 2026Colossal Biosciences in Talks to Raise at Up to $30B Valuation Pulse story
- Jan 2025Jan 2025Raised $200M Series C at a $10.2B valuation Wikipedia
Earlier changes (1)
- Jan 2025Jan 2025First reported total funding: $435M Wikipedia
Funding History
3 events · sources dated per row| Date | Event | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| Jul 20, 2026 | funding round | $20B | $30B | Pulse story | |
| Jan 1, 2025 | Series C | $200M | $10.2B | Wikipedia | |
| funding roundRumored | — | $20B–$30B | Pulse story |
Investors
Latest Pulse
- Aug 20, 2026Colossal Spinout Astromech Hits $3.8B on Biology AIAstromech, a Colossal Biosciences spinout co-founded by Ben Lamm and George Church, raised $20M at a $3.8B valuation to build AI models that predict evolutionary biological change.→
- Jul 20, 2026Colossal Biosciences in Talks to Raise at Up to $30B ValuationColossal Biosciences is reportedly in talks to raise new capital at a $20-30 billion valuation, up to triple its January 2025 mark, building revenue-generating spinouts beyond its mammoth and dire wolf projects.→
- Jul 20, 2026Colossal Biosciences in Talks to Raise at $20B-$30B ValuationDe-extinction genetics company Colossal Biosciences is reportedly in talks to raise new capital at a $20 billion to $30 billion valuation, a dramatic step up that would make it one of the most valuable biotech startups in the world.→
Coverage Timeline
newest firstAll Coverage
FUNDING$20M at $3.8B
Colossal Spinout Astromech Hits $3.8B on Biology AI
Astromech, a Colossal Biosciences spinout co-founded by Ben Lamm and George Church, raised $20M at a $3.8B valuation to build AI models that predict evolutionary biological change.
DEEP DIVE
FUNDING
Colossal Biosciences in Talks to Raise at Up to $30B Valuation
FUNDING$20B-$30B talks
Colossal Biosciences in Talks to Raise at Up to $30B Valuation
Colossal Biosciences is reportedly in talks to raise new capital at a $20-30 billion valuation, up to triple its January 2025 mark, building revenue-generating spinouts beyond its mammoth and dire wolf projects.
FUNDING
Colossal Biosciences in Talks to Raise at $20B-$30B Valuation
FUNDING$20B-$30B valuation
Colossal Biosciences in Talks to Raise at $20B-$30B Valuation
De-extinction genetics company Colossal Biosciences is reportedly in talks to raise new capital at a $20 billion to $30 billion valuation, a dramatic step up that would make it one of the most valuable biotech startups in the world.
Related Companies
Sources & methodologyshow
Where these figures come from
- TechCrunchmajor outlet2 facts
- Value Add Pulse researchValue Add VC data2 facts
- WikipediaValue Add VC data1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.